GlassScriptPhysician profile
Rebecca Kochanowicz
NPI 1033803044
$766.89
in general payments reported to CMS, 2019-2025
16 companies · $642 in 2025
The $642 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.01 · 2024: $111 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $227.98 | 2023-2025 | Airsupra, Breztri, Imfinzi |
| Corcept Therapeutics | $84.87 | 2025 | Korlym |
| Exact Sciences Corporation | $70.09 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $56.91 | 2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.46 | 2025 | Jardiance |
| Abbvie INC. | $41.20 | 2024-2025 | |
| Glaxosmithkline, LLC. | $39.72 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Biotech, INC. | $32.69 | 2024 | Rybrevant, Erleada, Akeega |
| Lilly USA, LLC | $25.17 | 2025 | Kisunla |
| Eisai INC. | $23.10 | 2025 | |
| Amgen INC. | $20.78 | 2025 | Repatha, Otezla |
| Abbott Laboratories | $19.15 | 2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $18.72 | 2024 | |
| Alnylam Pharmaceuticals INC. | $18.22 | 2025 | Givlaari |
| Bayer Healthcare Pharmaceuticals INC. | $17.12 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Kochanowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.